Joseph E. Levitt

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US

Shruti Gupta, Salim S. Hayek, Wei Wang et al. · JAMA Internal Medicine · 2020 · 1K citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +12

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial

Jennifer G. Wilson, Kathleen D. Liu, Hanjing Zhuo et al. · The Lancet Respiratory Medicine · 2014 · 792 citations · Full text

Engineering, Cell Biology, Surgery +11

Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial

Michael A. Matthay, Carolyn S. Calfee, Hanjing Zhuo et al. · The Lancet Respiratory Medicine · 2018 · 632 citations · Full text

Medicine, Immunology, Internal Medicine +16

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Shruti Gupta, Wei Wang, Salim S. Hayek et al. · JAMA Internal Medicine · 2020 · 555 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +16

A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients*

Shannon S. Carson, John P. Kress, Jo E. Rodgers et al. · Critical Care Medicine · 2006 · 334 citations

Health Professions, Anesthesiology, Pharmacotherapy +17